Special Issue "Natural Products from Marine Actinomycetes"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (28 February 2019) | Viewed by 77796
Interests: marine actinomycetes; natural products; NMR; structure elucidation; antibiotics; symbiosis; biosynthesis; genomics
Interests: marine natural prodcuts; structure elucidation of natural products; antibacteiral and anti-cancer natural products
Special Issues, Collections and Topics in MDPI journals
Actinobacteria had been recognized as an important chemical producer of bioactive secondary metabolites in the golden era of anticancer/antibiotic discovery. Unfortunately, the discovery of new bioactive natural products from this promising bacterial group has declined due to redundant studies on heavily investigated terrestrial actinomycetes. However, it has been increasingly highlighted that marine-derived actinomycetes are also very promising sources for discovering new secondary metabolites with pharmaceutical potential.
This Special Issue aims to integrate original research articles regarding studies of natural products from marine-derived actinomycetes including new natural products discovery, chemical biology, new methods for discovering secondary metabolites, structure elucidation, genomic and biosynthetic research of natural products, and new biological activities
Prof. Dr. Dong-Chan Oh
Prof. Dr. Sang-Jip Nam
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.